As airlines make free award tickets more expensive, fliers must get creative to earn enough miles for redemption.» Read More
As the likelihood of additional mergers in the airline industry dims, big United States carriers face a bleak future of making further cuts on their own to survive in an era of soaring jet fuel prices, the New York Times reported.
Nearly 2.2 billion shares and $36 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge. Here are the bets being made today...
Dow's CEO, Andrew Liveris, noted that first quarter feedstock and energy costs were up "a staggering 42 percent," putting strains on the company and its relations with customers. For most chemical companies, price increases have failed to keep up with raw material increases.
Despite a slew of disappointing economic news, the Dow, Nasdaq and S&P opened the trading week with slight gains, and CNBC asked the experts how to play the markets now.
Nearly 2.1 billion shares and $38 billion traded yesterday in CNBC's Million Dollar Portfolio Challenge. Here are the bets being made today...
Stocks plunged after the Federal Reserve cut its 2008 outlook and oil finished above $133 a barrel. The Dow shed more than 227 points, or 1.8 percent, bringing its two-day point decline to about 450.
When Air France-KLM reports on Thursday morning at 7:30 CET, it will be interesting to see how the world’s biggest airline by revenue views the prospects for what is likely to be a very difficult year.
American Airlines said it plans to cut jobs, retire old planes and slash domestic capacity by 11-12% in the fourth quarter as fuel prices reach record highs and the weak U.S. economy saps air travel demand.
Financially strapped airlines are cutting service, and nearly 30 cities across the United States have seen their scheduled service disappear in the last year.
Customer satisfaction with airlines in the United States has fallen to its lowest level since 2001, according to a survey published Tuesday.
Travelers to the Olympic Games this August in China better book airline tickets soon, but a dramatic buildup of Western hotels—many still just coming on-line —should make finding a room less of a challenge.
The chief executive officer of Delta Air Lines said Friday that his airline's pending merger with Northwest Airlines is on track and should be in force by next year.
United Airlines and Continental Airlines are talking about forming an alliance to gain some benefits of working together without going through a merger, which Continental rejected last month, a person close to the talks said.
We have all had some miserable customer service experiences and as we sit on hold or try to navigate through yet another voice response system, we wonder how can these companies get away with this. In fact, a 2006 Harris Interactive Poll showed 40% of us would rather go to the dentist than deal with poor customer service. My most recent mind numbing experience with my phone company, Verizon, made me wonder if there is a way to translate this into investing opportunities. Here is what I found...
I have been talking about the unwinding of the “long commodities/short dollar” trade. It continued today. Energy and materials sold off; tech and financials rose. Pray for an in-line or slightly stronger nonfarm payrolls report. ...Meantime, look what lower oil and consolidation talk has done to the airlines this week...
It's a booyah-free zone. There goes Swifty!
Following are the day’s biggest winners and losers. Find out why shares of Delta Airlines and Office Depot popped while Energizer and Altria dropped.
Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.
Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.
Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.